Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ollies Bargain Outlet Holdings, Inc. | OL6 | Nov 15, 2024 | 87.00 | +0.58 |
Olvi A | OVI | Nov 15, 2024 | 28.70 | +0.53 |
Olympic Steel, Inc. | OYS | Nov 15, 2024 | 36.40 | -2.67 |
Olympus Corp. | OLY1 | Nov 15, 2024 | 15.05 | -0.76 |
OLYMPUS CORP. ADR | OLY | Nov 15, 2024 | 14.50 | -1.36 |
Oma Säästöpankki | OM0 | Nov 15, 2024 | 10.82 | -1.81 |
Omai Gold Mines Corp | 0N2 | Nov 15, 2024 | 0.10 | 0.00 |
Omega Diagnostics Group Plc | RVKA | Nov 15, 2024 | 0.03 | 0.00 |
Omega Healthcare Investors, Inc. | WX4 | Nov 15, 2024 | 38.32 | +1.73 |
OMEGA PACIFIC RESOURCES | Q0F | Nov 15, 2024 | 0.22 | +2.86 |
Omer S.p.a | 9WR | Nov 15, 2024 | 4.06 | +1.50 |
Omer-Decugis & Cie | 0VC | Nov 15, 2024 | 4.44 | +0.23 |
Omeros Corporation | 3O8 | Nov 15, 2024 | 6.38 | +59.06 |
Omni Bridgeway Limited | MXG1 | Nov 15, 2024 | 0.55 | +2.80 |
Omnia Holdings Ltd | OHZ | Nov 15, 2024 | 3.44 | +1.18 |
Omnicell, Inc. | OC9 | Nov 15, 2024 | 43.60 | -0.91 |
Omnicom Group Inc. | OCN | Nov 15, 2024 | 94.72 | -2.63 |
OMV AG | OMVI | Nov 15, 2024 | 9.40 | +0.53 |
OMV AG | OMV | Nov 15, 2024 | 37.88 | -0.58 |
ON Semiconductor Corporation | XS4 | Nov 15, 2024 | 61.35 | -3.45 |
On the Beach Group plc | 9BP | Nov 15, 2024 | 1.87 | +1.63 |
Oncimmune Holdings plc | OCY | Nov 15, 2024 | 0.13 | 0.00 |
Oncoarendi Therapeutics SA | 1B1 | Nov 15, 2024 | 2.17 | +0.93 |
ONCODES.PREC.MED. EO-,34 | ZR8 | Nov 15, 2024 | 1.00 | 0.00 |
Onconova Therapeutics, Inc. | 0T2 | Nov 15, 2024 | 6.60 | 0.00 |
Oncopeptides | OND | Nov 15, 2024 | 0.07 | -8.81 |
Oncotherpapy Science Inc | 30O | Nov 15, 2024 | 0.13 | +1.52 |
OncoZenge | 8LY | Nov 15, 2024 | 0.70 | +0.14 |
ONDAS HLDGS INC. DL-,0001 | 1B8 | Nov 15, 2024 | 0.66 | -3.65 |
Onde S.A. | 0XF | Nov 15, 2024 | 2.19 | -0.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.